Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

The WHO says monkeypox is still a global health emergency of concern, despite a 'promising' decline in cases

Despite a promising decline in global cases, the World Health Organization has determined that monkeypox should remain a "public health emergency of international concern". Here's why.

ABC News

The health care cost wars may be coming to a head

If they do, the political fallout will be defined by industry group brawling.

Axios

A Multi-National Mega Corp Trialled The 4-Day Work Week Got Great Results So Let’s Goooo

If even Unilever, of all companies, is allowing its staff a 4 day work week then we know that shit works.

Pedestrian.tv

From analysis to the latest developments in health,
read the most diverse news in one place.

CSL paying $312m to license mRNA vax tech

CSL Seqirus is paying $A312 million up-front to license next-generation mRNA technology from a small US company, Arcturus Therapeutics.

AAP

Cannabis Terpenes Reduce Inflammation, Says Gb Sciences Study

Gb Sciences, Inc. (OTCQB: GBLX), a leading plant-inspired, biopharmaceutical research and drug development company, co-published a study that demonstrates the potential of selected cannabinoids and terpenes to reduce inflammation.

Benzinga

Ketamine Could Soon Be A Treatment Option For This Rare Genetic Neurological Disorder

Specialty biopharma company PharmaTher Holdings Ltd. (OTCQB: PHRRF) has entered into an evaluation and exclusive option agreement with Case Western Reserve University (CWRU)

Benzinga

Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know

Editor's note: This story has been corrected to reflect that the FDA deferred action on Amicus Therapeutics' Biologics License Application.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

The Worst Biotech Stocks Investors Could Buy This Fall

Timber Pharmaceuticals (TMBR) recently received an NYSE warning for not meeting the minimum trading price requirement for quite some time. The stock has lost 84% year-to-date. Given the company’s weak fundamentals, the stock could be a poor choice for investors enticed by its negligible price. Let’s discuss….

StockNews.com

Australian workers to trial four-day week

Consumer goods giant Unilever is expanding its four-day work week trial to Australia after impressive results in New Zealand.

AAP

How coal miners and factory workers helped found the environmental movement

Rachel Carson, a scientist and writer from rural Pennsylvania, published Silent Spring 60 years ago. Many credit this book, which meticulously documented the damage that DDT pesticides were inflicting on wildlife, farm animals and people as early as the 1950s, with launching the modern environmental movement.

The Conversation

The Three Pillars of Effective Ketamine Mental Health Treatment

By Kevin Nicholson, COO of Delic and CEO of Ketamine Wellness Centers

Benzinga

Psyched: Top Psychedelics Execs., 50% Of Americans Support Medical Psychedelics, Cary Grant's LSD Therapy & More

15 Global Psychedelics Executives To Keep An Eye On In 2022

Benzinga

Ask an Immunity Expert: What’s Next for COVID-19?

This pandemic can help us prepare for the next one, says Catherine Hankins, co-chair of Canada’s COVID-19 Immunity Task Force

The Walrus

Indonesia revokes drug companies' licenses after 159 deaths

Indonesian authorities have revoked the licenses of two pharmaceutical companies to produce syrup-type medicines following the deaths of 159 children due to acute kidney injury

The Independent UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

How long can you test positive for Covid and when are you infectious?

A surge in cases is indicating a new wave has started in the UK

The Independent UK

Nine Covid symptoms affecting the fully vaccinated — and signs you may have it

Fainting and fatigue may signal onset of variant, experts say

The Independent UK

Who can get an autumn Covid booster jab and how do I book?

Booster vaccinations are being offered to everyone in England over the age of 50

Axios

RSV vaccine search could hit third piece of "tripledemic" threat

We've got COVID boosters and flu shots. But there's a missing piece in this triad of tools to cope with what's been dubbed the tripledemic: an RSV vaccine. That could soon change.

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Strong RSV vaccine data lifts hopes after years of futility

A new study suggests vaccinating pregnant women protects their newborns from the common but scary respiratory virus called RSV

The Independent UK

Covid remains deadly for half a million Britons, and the government isn’t talking about it

As immunocompromised people and their families face a third housebound winter, Charlotte Lytton asks why the government is dragging its feet when it comes to the possibly life-altering drug Evusheld. It remains punishingly out of reach… unless you cough up the money for it

Tribune News Service

Study finds COVID-19 symptoms recur more often in those who took Paxlovid to ease illness

SAN DIEGO — You've been free of COVID-19 symptoms for two days. Then the coughing, fatigue and headaches return. Join the growing number of people experiencing what's being called COVID rebound.

Reuters

Indonesia revokes firms' fever syrup licences amid inquiry into 150 deaths

Indonesia's food and drug agency said on Monday it had revoked licences for syrup-type drug production by two local firms for violating manufacturing rules, as it investigates the deaths of more than 150 children due to acute kidney injury (AKI).

The Independent UK

Antibody treatment tested as new tool against malaria

Research in Africa has found a one-time dose of an experimental drug protected adults against malaria for at least six months

Inverse

Scientists use mRNA technology to create a potent flu shot that could last for years

Researchers have created an mRNA-based influenza vaccine that targets four viral proteins that tend to remain the same across different strains of influenza.

StockNews.com

2 Pharma Stocks You'll Want to Pay Attention to This Fall

Although the stock market has been under pressure this year due to macroeconomic headwinds, the pharmaceutical industry continues to garner investor attention as it enjoys inelastic demand for its products regardless of economic conditions. Thus, fundamentally-sound pharma stocks Eli Lilly (LLY) and Bristol-Myers Squibb (BMY) could be worth your attention…

1 … 109 110 111 112

People

Rob

931 stories

Tedros Adhanom Ghebreyesus

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Food and Drug Administration

Michigan State University

BristolMyers Squibb Company

95 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.